摘要
目的分析20%人血白蛋白胸腔内注射治疗顽固性气胸的临床价值。方法选取2010年1月～2012年11月在我院进行治疗的顽固性气胸患者36例,分为两组,分别采用20%人血白蛋白胸腔内注射的方法治疗和高渗糖治疗。结果实验组中20%人血白蛋白治愈率为94.4%,高于对照组的83.3%并且仅有3例患者出现轻度的疼痛,低热患者为2例,无重度胸痛的患者,疗效明显好于传统的高渗糖组。结论 20%人血白蛋白可以应用于顽固性气胸的治疗,且操作简便易于掌握,可在临床上进一步推广。
Objective This Study aims to analyze the clinical value of 20% human serum albumin on intractable pneumothoraxby intrapleural injection. Methods 36 cases of intractable pneumothorax patients who were admitted into our hospital from Jan. 2010 to Nov. 2012 were divided into two groups, and treated with 20% human serum alblJminby intrapleural injection and hyperosmotic glucose respectively. Results The recovery rate of experimentaltreated by 20% httman serua]bumia was 94.4%, the curative effect was superior to control group which was 83.33% Only 3 cases of mild poir sad 2 cases of low-grade fever occurred, meanwhile, no patients got severe chest pair, The crative effect of 20% human serum albumin was superior to hyperosmotic glucose. Conclusion 20% human serum albumin can be applied in the treatment of intractable pneumothorax, it has a characteristic of easy operation and learnability,and worth to be promoted in clinical therapy.
出处
《中国医药科学》
2013年第12期57-58,72,共3页
China Medicine And Pharmacy
关键词
人血白蛋白
顽固性气胸
治疗
安全性
Human serum albumin
Intractable pneumothorax
Therapy
Safety
